Clinical Trial Update: Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated sirolimus for treating chronic graft-versus-host disease that is either steroid-refractory or steroid-dependent; the trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Stanford University | Conditions: Graft vs Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-04-21